ARTICLE | Company News
Theravance, Merck deal
October 22, 2012 7:00 AM UTC
Theravance and Merck partnered to discover, develop and commercialize small molecules directed toward an undisclosed target for hypertension and heart failure. Theravance will be responsible for disco...